The aging-disease false dichotomy: Understanding senescence as pathology

Frontiers in Genetics

Volumn 6, Issue JUN, 2015, Pages

  Gems, David ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Aging; Disease; Evolution; Pathology; Senescence

Indexed keywords

INSULIN; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C RECEPTOR; TARGET OF RAPAMYCIN KINASE;

AGING; ALZHEIMER DISEASE; DEATH; EVOLUTION; FITNESS; GENE MUTATION; GENETIC DISORDER; GERIATRIC DISORDER; GERONTOLOGIST; GERONTOLOGY; HUMAN; LIFESPAN; MORBIDITY; NEOPLASM; NONHUMAN; PATHOLOGY; PLEIOTROPY; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION;

EID: 84940101423     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2015.00212     Document Type: Review

References (44)

1. Ayyadevara, S., Alla, R., Thaden, J. J., and Shmookler Reis, R. J. (2008). Remarkable longevity and stress resistance of nematode PI3K-null mutants. Aging Cell 7, 13-22. doi: 10.1111/j.1474-9726.2007.00348.x.
2. Bartke, A., Sun, L. Y., and Longo, V. (2013). Somatotropic signaling: trade-offs between growth, reproductive development, and longevity. Physiol. Rev. 93, 571-598. doi: 10.1152/physrev.00006.2012.
3. Barzilai, N. (2014). Elder pharmacology. The Scientist, 1st January 2014. Available at: http://www.the-scientist.com/?articles.view/articleNo/38688/title/Elder-Pharmacology/.
4. Blagosklonny, M. V. (2006). Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition. Cell Cycle 5, 2087-2102. doi: 10.4161/cc.5.18.3288.
5. Blagosklonny, M. V. (2008). Aging: ROS or TOR. Cell Cycle 7, 3344-3354. doi: 10.4161/cc.7.21.6965.
6. Blagosklonny, M. V. (2010). Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program. Cell Cycle 9, 3151-3156. doi: 10.4161/cc.9.16.13120.
7. Blagosklonny, M. V. (2012). How to save medicare: the anti-aging remedy. Aging 4, 547-552.
8. Butler, R. N., Miller, R. A., Perry, D., Carnes, B. A., Williams, T. F., Cassel, C., et al. (2008). New model of health promotion and disease prevention for the 21st century. BMJ 337, a399. doi: 10.1136/bmj.a399.
9. Callahan, D. (1994). Aging and the goals of medicine. Hastings Cent. Rep. 24, 39-41. doi: 10.2307/3563499.
10. Campisi, J. (2013). Aging, cellular senescence, and cancer. Ann. Rev. Physiol. 75, 685-705. doi: 10.1146/annurev-physiol-030212-183653.
11. Caplan, A. (1992). "Is aging a disease?," in If I were a rich man could I buy a pancreas?, ed. A. Caplan (Bloomington: Indiana University Press), 195-209.
12. Caplan, A. L. (2005). Death as an unnatural process. Why is it wrong to seek a cure for aging? EMBO Rep. 6, S72-S75. doi: 10.1038/sj.embor.7400435.
13. Comfort, A. (1979). The Biology of Senescence. New York: Elsevier.
14. de Grey, A. D., Ames, B. N., Andersen, J. K., Bartke, A., Campisi, J., Heward, C. B., et al. (2002). Time to talk SENS: critiquing the immutability of human aging. Ann. N. Y. Acad. Sci. 959, 452-462. doi: 10.1111/j.1749-6632.2002.tb02115.x.
15. de Magalhães, J. P. (2012). Programmatic features of aging originating in development: aging mechanisms beyond molecular damage? FASEB J. 26, 4821-4826. doi: 10.1096/fj.12-210872.
16. Fries, J. F., Bruce, B., and Chakravarty, E. (2011). Compression of morbidity 1980-2011: a focused review of paradigms and progress. J. Aging Res. 2011, 261702. doi: 10.4061/2011/261702.
17. Fukuyama, F. (2002). Our Posthuman Future: The Consequences of the Biotechnology Revolution. London: Profile Books.
18. Garigan, D., Hsu, A., Fraser, A., Kamath, R., Ahringer, J., and Kenyon, C. (2002). Genetic analysis of tissue aging in Caenorhabditis elegans: a role for heat-shock factor and bacterial proliferation. Genetics 161, 1101-1112.
19. Gems, D. (2014). What is an anti-aging treatment? Exp. Gerontol. 58, 14-18. doi: 10.1016/j.exger.2014.07.003.
20. Gladyshev, V. N. (2013). The origin of aging: imperfectness-driven non-random damage defines the aging process and control of lifespan. Trends Genet. 29, 506-512. doi: 10.1016/j.tig.2013.05.004.
21. Haber, C. (2004). Life extension and history: the continual search for the fountain of youth. J. Gerontol. 59, B515-B522. doi: 10.1093/gerona/59.6.B515.
22. Haldane, J. B. S. (1941). New Paths in Genetics. London: Allen and Unwin.
23. Harman, D. (1956). Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11, 298-300. doi: 10.1093/geronj/11.3.298.
24. Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., et al. (2009). Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392-395. doi: 10.1038/nature08221.
25. Herndon, L., Schmeissner, P., Dudaronek, J., Brown, P., Listner, K., Sakano, Y., et al. (2002). Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature 419, 808-814. doi: 10.1038/nature01135.
26. Holliday, R. (1996). The urgency of research on ageing. BioEssays 18, 89-90. doi: 10.1002/bies.950180202.
27. Kass, L. (1983). The case for mortality. Am. Scholar. 52, 173-191.
28. Kass, L. R. (1988). "Mortality and morality: the virtues of finitude," in Toward a More Natural Science: Biology and Human Affairs, ed. L. R. Kass (New York: The Free Press).
29. Kenyon, C. (2010). The genetics of ageing. Nature 464, 504-512. doi: 10.1038/nature08980.
30. Kirkwood, T., and Austad, S. (2000). Why do we age? Nature 408, 233-238. doi: 10.1038/35041682.
31. Kirkwood, T. B. L., and Rose, M. R. (1991). Evolution of senescence: late survival sacrificed for reproduction. Philos. Trans. R. Soc. Lond. B Biol. Sci. 332, 15-24. doi: 10.1098/rstb.1991.0028.
32. Kulminski, A., Ukraintseva, S. V., Akushevich, I., Arbeev, K. G., Land, K., and Yashin, A. I. (2007). Accelerated accumulation of health deficits as a characteristic of aging. Exp. Gerontol. 42, 963-970. doi: 10.1016/j.exger.2007.05.009.
33. Longo, V. D., Mitteldorf, J., and Skulachev, V. P. (2005). Programmed and altruistic ageing. Nat. Rev. Genet. 6, 866-872. doi: 10.1038/nrg1706.
34. López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., and Kroemer, G. (2013). The hallmarks of aging. Cell 153, 1194-1217. doi: 10.1016/j.cell.2013.05.039.
35. Luo, S., Kleemann, G. A., Ashraf, J. M., Shaw, W. M., and Murphy, C. T. (2010). TGF-beta and insulin signaling regulate reproductive aging via oocyte and germline quality maintenance. Cell 143, 299-312. doi: 10.1016/j.cell.2010.09.013.
36. Medawar, P. B. (1952). An Unsolved Problem Of Biology. London: H. K. Lewis.
37. Peto, R., and Doll, R. (1997). There is no such thing as aging. BMJ 315, 1030-1032. doi: 10.1136/bmj.315.7115.1030.
38. Rattan, S. I. S. (2014). Aging is not a disease: implications for intervention. Aging Dis. 5, 196-202. doi: 10.14336/AD.2014.0500196.
39. Rockwood, K., and Mitnitski, A. (2007). Frailty in relation to the accumulation of deficits. J. Gerontol. 62A, 722-727. doi: 10.1093/gerona/62.7.722.
40. Sohal, R. S., and Weindruch, R. (1996). Oxidative stress, caloric restriction, and aging. Science 273, 59-63. doi: 10.1126/science.273.5271.59.
41. Van Raamsdonk, J. M., and Hekimi, S. (2010). Reactive oxygen species and aging in Caenorhabditis elegans: causal or casual relationship? Antioxid. Redox Signal. 13, 1911-1953. doi: 10.1089/ars.2010.3215.
42. Vijg, J., and Suh, Y. (2013). Genome instability and aging. Ann. Rev. Physiol. 75, 645-668. doi: 10.1146/annurev-physiol-030212-183715.
43. Wald, N. J., and Law, M. R. (2003). A strategy to reduce cardiovascular disease by more than 80%. BMJ 326, 1419. doi: 10.1136/bmj.326.7404.1419.
44. Williams, G. C. (1957). Pleiotropy, natural selection and the evolution of senescence. Evolution 11, 398-411. doi: 10.2307/2406060.